SPECTRUM PHARMACEUTICALS
Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus on oncology. It has a strong track record for in-licensing and acquiring differentiated drugs, and for clinical development.
SPECTRUM PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Medical Oncology
Founded:
1987-01-01
Address:
Henderson, Nevada, United States
Country:
United States
Website Url:
http://www.sppirx.com
Total Employee:
101+
Status:
Active
Contact:
9497886706
Email Addresses:
[email protected]
Total Funding:
235.98 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Analytics Content Delivery Network
Similar Organizations
AEterna Zentaris
AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
CytRx
CytRx is a biopharmaceutical research and development company specializing in oncology.
erytech
ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
Kura Oncology
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-07-17 | TALON THERAPEUTICS | TALON THERAPEUTICS acquired by Spectrum Pharmaceuticals | 11.3 M USD |
| 2012-09-06 | Allos Therapeutics | Allos Therapeutics acquired by Spectrum Pharmaceuticals | N/A |
Investors List
SLR Capital Partners
SLR Capital Partners investment in Post-IPO Debt - Spectrum Pharmaceuticals
Hanmi Pharmaceutical
Hanmi Pharmaceutical investment in Post-IPO Equity - Spectrum Pharmaceuticals
Par Pharmaceuticals
Par Pharmaceuticals investment in Post-IPO Equity - Spectrum Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Spectrum Pharmaceuticals
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Spectrum Pharmaceuticals
SDS Capital Group
SDS Capital Group investment in Post-IPO Equity - Spectrum Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.sppirx.com
- Host name: redirect.idp365.net
- IP address: 217.19.248.132
- Location: Milton Keynes United Kingdom
- Latitude: 52.0675
- Longitude: -0.7569
- Timezone: Europe/London
- Postal: MK14
More informations about "Spectrum Pharmaceuticals"
Spectrum Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number 9497886706 Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a …See details»
Spectrum Pharmaceuticals - Wikipedia
Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology. After a deal valued at $248 million was announced in April 2023, Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based …See details»
Company Profile for SPECTRUM PHARMACEUTICALS - Business Wire
Apr 27, 2018 Company: SPECTRUM PHARMACEUTICALS Headquarters Address: 11500 S. Eastern Avenue #240See details»
2012 Annual Report - sppirx.com
As a Company with a productive history of product acquisitions, we intend to continue our business-building activities going forward. SPECTRUM PHARMACEUTICALSSee details»
Spectrum Pharmaceuticals Inc - Company Profile - GlobalData
This product is in phase 3 trails.; Poziotinib, an irreversible tyrosine kinase inhibitor, for non-small cell lung cancer (NSCLC) tumors with various mutations. This product is in phase 2 trials and …See details»
Company Profile for SPECTRUM PHARMACEUTICALS - BioSpace
Apr 27, 2018 Spectrum's strong track record for in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing …See details»
Spectrum Pharmaceuticals Announces Changes to ... - Business Wire
Dec 1, 2021 Kurt Gustafson Chief Financial Officer 949.788.6700 [email protected] Release Summary Spectrum Pharmaceuticals Announces Changes to Management Team …See details»
Document - SEC.gov
2 Atlantic Avenue, 6th Floor • Boston, Massachusetts 02110 • Tel: (617) 586-3900 • www.sppirx.com • NASDAQ: SPPI Selling, general and administrative expenses for the …See details»
The Collier Report's Dossier on Spectrum Pharmaceuticals INC
Founded in 1997, Spectrum Pharmaceuticals Inc's contact person is Lisa Nguyen at 949-743-9301 with estimated revenues of $204,000 and 70 employees. Spectrum Pharmaceuticals …See details»
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc.
Apr 25, 2023 Transaction Expected to Be Accretive to Assertio’s Adjusted EPS and Operating Cash Flow in 2024. Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 …See details»
Assertio Holdings, Inc. to Acquire Spectrum - GlobeNewswire
Apr 25, 2023 In addition, investors and stockholders will be able to obtain free copies of the joint proxy statement/prospectus and other documents filed with the SEC by Assertio and Spectrum …See details»
Assertio Holdings, Inc. Announces Favorable Vote on Proposed
Jul 27, 2023 Nora Brennan Chief Financial OfficerM: [email protected] Lisa Wilson In-Site Communications, Inc. 212-452-2793 …See details»
Spectrum Pharmaceuticals Announces Strategic Expansion and …
Nov 1, 2012 About Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, …See details»
Spectrum Pharmaceuticals Announces Changes to Management
Dec 1, 2021 HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology …See details»
Independent Proxy Advisory Firms ISS and Glass Lewis …
Jul 20, 2023 Copies of the documents filed with the SEC by Spectrum will be available free of charge on Spectrum’s website at www.sppirx.com or by contacting Spectrum’s Investor …See details»
Working at Spectrum Pharmaceuticals - Zippia
Mar 14, 2024 www.sppirx.com. Organization Type. Public. CEO. Joseph W. Turgeon. Spectrum Pharmaceuticals is a commercial-stage biotechnology company with fully integrated …See details»
Spectrum Pharmaceuticals Sells Marketed Portfolio to ... - BioSpace
Jan 17, 2019 Spectrum’s strong track record for in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing …See details»
Spectrum Pharmaceuticals Regains Compliance with Nasdaq …
May 17, 2023 Nora Brennan Chief Financial Officer 949.788.6700 [email protected] Lisa Wilson In-Site Communications, Inc. 212.452.2793 …See details»
sppirx.com Reviews: Is this site a scam or legit?
Is sppirx.com a scam? Is it legit or something that raises red flags? This thorough review provides an overview of its strengths and weaknesses.See details»
Spectrum Pharmaceuticals Provides Update on Poziotinib …
Sep 22, 2022 Tom Riga Chief Executive Officer 949.788.6700 [email protected]. Lisa Wilson In-Site Communications, Inc. 212.452.2793 [email protected]. Site …See details»